ArticleFrontiers in aging neuroscience2025
Uncovering abnormal gray and white matter connectivity patterns in Alzheimer's disease spectrum: a dynamic graph theory analysis for early detection.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Alzheimer's disease (AD) requires early intervention at preclinical stages like subjective memory complaints (SMC). Traditional static brain network analyses lack sensitivity to detect early functional disruptions in SMC. This study aimed to improve preclinical AD stratification by integrating dynamic gray-white matter functional connectivity (DFC) and machine learning. Methods: Using multi-cohort ADNI data [ Results: DFC with short sliding windows (20-50 TRs, 98% overlap) demonstrated greater sensitivity than SFC in detecting early functional disruptions in gray-white matter networks, identifying 34 CN-SMC [ Conclusion: This study confirms that dynamic gray-white matter connectivity serves as a sensitive biomarker for preclinical Alzheimer's disease. The WM4-WM5 disruption hub and machine learning framework provide effective tools for early stratification of SMC, facilitating timely intervention within the disease's therapeutic window.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.